These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Synthesis and evaluation of a high relaxivity manganese(II)-based MRI contrast agent. Troughton JS; Greenfield MT; Greenwood JM; Dumas S; Wiethoff AJ; Wang J; Spiller M; McMurry TJ; Caravan P Inorg Chem; 2004 Oct; 43(20):6313-23. PubMed ID: 15446878 [TBL] [Abstract][Full Text] [Related]
4. Laser flash photolysis generation and kinetic studies of porphyrin-manganese-oxo intermediates. Rate constants for oxidations effected by porphyrin-Mn(V)-oxo species and apparent disproportionation equilibrium constants for porphyrin-Mn(IV)-oxo species. Zhang R; Horner JH; Newcomb M J Am Chem Soc; 2005 May; 127(18):6573-82. PubMed ID: 15869278 [TBL] [Abstract][Full Text] [Related]
5. Manganese ferrite nanoparticle micellar nanocomposites as MRI contrast agent for liver imaging. Lu J; Ma S; Sun J; Xia C; Liu C; Wang Z; Zhao X; Gao F; Gong Q; Song B; Shuai X; Ai H; Gu Z Biomaterials; 2009 May; 30(15):2919-28. PubMed ID: 19230966 [TBL] [Abstract][Full Text] [Related]
6. Development of a dendritic manganese-enhanced magnetic resonance imaging (MEMRI) contrast agent: synthesis, toxicity (in vitro) and relaxivity (in vitro, in vivo) studies. Bertin A; Steibel J; Michou-Gallani AI; Gallani JL; Felder-Flesch D Bioconjug Chem; 2009 Apr; 20(4):760-7. PubMed ID: 19368343 [TBL] [Abstract][Full Text] [Related]
7. Mn12 single-molecule magnet aggregates as magnetic resonance imaging contrast agents. Wang Y; Li W; Zhou S; Kong D; Yang H; Wu L Chem Commun (Camb); 2011 Mar; 47(12):3541-3. PubMed ID: 21327273 [TBL] [Abstract][Full Text] [Related]
8. Hydrogen atom transfer reactions of imido manganese(V) corrole: one reaction with two mechanistic pathways. Zdilla MJ; Dexheimer JL; Abu-Omar MM J Am Chem Soc; 2007 Sep; 129(37):11505-11. PubMed ID: 17718564 [TBL] [Abstract][Full Text] [Related]
9. Rigid Mn(II) chelate as efficient MRI contrast agent for vascular imaging. Su H; Wu C; Zhu J; Miao T; Wang D; Xia C; Zhao X; Gong Q; Song B; Ai H Dalton Trans; 2012 Dec; 41(48):14480-3. PubMed ID: 23108333 [TBL] [Abstract][Full Text] [Related]
10. An amphiphilic bisporphyrin and its Yb(III) complex: development of a bifunctional photodynamic therapeutic and near-infrared tumor-imaging agent. Jiang FL; Poon CT; Wong WK; Koon HK; Mak NK; Choi CY; Kwong DW; Liu Y Chembiochem; 2008 May; 9(7):1034-9. PubMed ID: 18383057 [No Abstract] [Full Text] [Related]
11. An MRI-sensitive, non-photobleachable porphysome photothermal agent. MacDonald TD; Liu TW; Zheng G Angew Chem Int Ed Engl; 2014 Jul; 53(27):6956-9. PubMed ID: 24840234 [TBL] [Abstract][Full Text] [Related]
12. Separation and characterization of the two diastereomers for [Gd(DTPA-bz-NH2)(H2O)]2-, a common synthon in macromolecular MRI contrast agents: their water exchange and isomerization kinetics. Burai L; Tóth E; Sour A; Merbach AE Inorg Chem; 2005 May; 44(10):3561-8. PubMed ID: 15877439 [TBL] [Abstract][Full Text] [Related]
13. Metalloporphyrin contrast agents for magnetic resonance imaging of human tumors in mice. Patronas NJ; Cohen JS; Knop RH; Dwyer AJ; Colcher D; Lundy J; Mornex F; Hambright P; Sohn M; Myers CE Cancer Treat Rep; 1986 Mar; 70(3):391-5. PubMed ID: 3955550 [TBL] [Abstract][Full Text] [Related]
14. Manganese protoporphyrin IX. A potential intravenous paramagnetic NMR contrast agent: preliminary communication. Jackson LS; Nelson JA; Case TA; Burnham BF Invest Radiol; 1985; 20(2):226-9. PubMed ID: 3988477 [TBL] [Abstract][Full Text] [Related]
15. Laser flash photolysis generation and kinetic studies of corrole-manganese(V)-oxo intermediates. Zhang R; Harischandra DN; Newcomb M Chemistry; 2005 Sep; 11(19):5713-20. PubMed ID: 16034998 [TBL] [Abstract][Full Text] [Related]
16. A manganese-ferritin nanocomposite as an ultrasensitive T2 contrast agent. Sana B; Poh CL; Lim S Chem Commun (Camb); 2012 Jan; 48(6):862-4. PubMed ID: 22125796 [TBL] [Abstract][Full Text] [Related]
17. Reduction/dissolution of a beta-MnOOH nanophase in the ferritin cavity to yield a highly sensitive, biologically compatible magnetic resonance imaging agent. Kálmán FK; Geninatti-Crich S; Aime S Angew Chem Int Ed Engl; 2010; 49(3):612-5. PubMed ID: 20013829 [No Abstract] [Full Text] [Related]
18. Pushing the sensitivity envelope of lanthanide-based magnetic resonance imaging (MRI) contrast agents for molecular imaging applications. Aime S; Castelli DD; Crich SG; Gianolio E; Terreno E Acc Chem Res; 2009 Jul; 42(7):822-31. PubMed ID: 19534516 [TBL] [Abstract][Full Text] [Related]
19. A Gd3+-based magnetic resonance imaging contrast agent sensitive to beta-galactosidase activity utilizing a receptor-induced magnetization enhancement (RIME) phenomenon. Hanaoka K; Kikuchi K; Terai T; Komatsu T; Nagano T Chemistry; 2008; 14(3):987-95. PubMed ID: 17992679 [TBL] [Abstract][Full Text] [Related]
20. Mechanism of catalytic aziridination with manganese corrole: the often postulated high-valent Mn(V) imido is not the group transfer reagent. Zdilla MJ; Abu-Omar MM J Am Chem Soc; 2006 Dec; 128(51):16971-9. PubMed ID: 17177448 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]